SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...
SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...
Apogee Therapeutics reports early trial data showing its asthma drug APG777 sharply reduced a key inflammation marker for up ...
Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...
A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
Blue Cross Blue Shield is changing how some asthma injections are given, sparking concerns from doctors. Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is ...
New ‘life-changing’ asthma drug gets green light after rise in hospital admissions - A trial cut hospital admissions by 72 ...
An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available in Britain. Pharmaceutical giant GSK has been granted marketing ...
OKLAHOMA CITY (KFOR) — Next month, Oklahomans with severe asthma who are insured with BlueCross and BlueShield of Oklahoma (BCBSOK), may have to give themselves life-saving shots at home after a ...
An asthma medication coverage policy by Health Care Services Corp. and its Illinois health plans that may lead to more at-home self-injections is meeting resistance from allergists, patients and an ...
Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is changing how certain asthma injections are administered. Effective April 15, 2025, some patients will need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results